Healthequity, Inc.

The Company repurchased 0.7 million shares of its common stock for $66.0 million.

SEC original ↗Healthequity, Inc. — Earnings release (8-K exhibit)EX-99Sep 2, 2025

Stock repurchase program The Company repurchased 0.7 million shares of its common stock for $66.0 million during the second quarter ended July 31, 2025.

SEC original ↗Healthequity, Inc. — Earnings release (8-K exhibit)EX-99Sep 2, 2025

As of July 31, 2025, $351.8 million of common stock remained authorized for repurchase under the Company's stock repurchase programs.

SEC original ↗Healthequity, Inc. — Earnings release (8-K exhibit)EX-99Sep 2, 2025

Non-GAAP net income is calculated by adding back to GAAP net income before income taxes the following items amortization of acquired intangible assets, stock-based compensation expense, merger integration expenses, acquisition costs, gains and losses on equity securities, costs associated with unused office space, and losses on extinguishment of debt, and subtracting a non-GAAP tax provision using a normalized non-GAAP tax rate.

SEC original ↗Healthequity, Inc. — Earnings release (8-K exhibit)EX-99Sep 2, 2025

Forward-looking statements This press release contains forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, including but not limited to, statements regarding our industry, business strategy, plans, goals and expectations concerning our markets and market position, product expansion, future operations, expenses and other results of operations, revenue, margins, profitability, acquisition synergies, future efficiencies, tax rates, capital expenditures, liquidity and capital resources and other financial and operating information.

SEC original ↗Healthequity, Inc. — Earnings release (8-K exhibit)EX-99Sep 2, 2025

Non-GAAP net income Calculated by adding back to GAAP net income before income taxes the following items amortization of acquired intangible assets, stock-based compensation expense, merger integration expenses, acquisition costs, gains and losses on equity securities, costs associated with unused office space, and losses on extinguishment of debt, and subtracting a non-GAAP tax provision using a normalized non-GAAP tax rate.

SEC original ↗Healthequity, Inc. — Earnings release (8-K exhibit)EX-99Sep 2, 2025

We believe our outlook is even brighter with our national lawmakers providing the largest legislative expansion of HSAs since 2006 as more American families seek access to the financial security and tax benefits that they provide.

SEC original ↗Healthequity, Inc. — Earnings release (8-K exhibit)EX-99Sep 2, 2025

Forward-looking statements This press release contains forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, including but not limited to, statements regarding our industry, business strategy, plans, goals and expectations concerning our markets and market position, product expansion, future operations, expenses and other results of operations, revenue, margins, profitability, acquisition synergies, future efficiencies, tax rates, capital expenditures, liquidity and capital resources and other financial and operating information.

SEC original ↗Healthequity, Inc. — Earnings release (8-K exhibit)EX-99Sep 2, 2025

The CODM assesses the performance of the Company, monitors actual financial results against budgets, and makes resource allocation decisions with a focus on the Company s consolidated results as presented in the condensed consolidated statements of operations.

SEC original ↗Healthequity, Inc. — 10-Q Quarterly report10-QAug 27, 2026

Our selective acquisition strategy We have historically acquired HSA portfolios and businesses that we believe strengthen our service offerings.

SEC original ↗Healthequity, Inc. — 10-Q Quarterly report10-QAug 27, 2026

We expect to continue this growth strategy and are regularly engaged in evaluating different opportunities.

SEC original ↗Healthequity, Inc. — 10-Q Quarterly report10-QAug 27, 2026

Actual events, results and outcomes may differ materially from our expectations due to a variety of known and unknown risks, uncertainties and other factors.

SEC original ↗Healthequity, Inc. — Earnings release (8-K exhibit)EX-99Sep 2, 2025

Legal proceedings 38 Item 1A.

SEC original ↗Healthequity, Inc. — 10-Q Quarterly report10-QAug 27, 2026

Legal matters As a result of a cybersecurity incident in fiscal 2025 in which a business partner's user account containing personally identifiable information was breached, the Company is subject to a consolidated putative class action lawsuit in federal court in the District of Utah.

SEC original ↗Healthequity, Inc. — 10-Q Quarterly report10-QAug 27, 2026

The amount of the potential loss associated with the lawsuit and any potential regulatory action cannot be reasonably estimated based on currently available information.

SEC original ↗Healthequity, Inc. — 10-Q Quarterly report10-QAug 27, 2026

The Company and its subsidiaries are involved in various other litigation, governmental proceedings, and claims, not described above, that arise in the normal course of business.

SEC original ↗Healthequity, Inc. — 10-Q Quarterly report10-QAug 27, 2026

It is not possible to determine the ultimate outcome or the duration of such litigation, governmental proceedings or claims, or the impact that such litigation, proceedings, and claims will have on the Company s financial position, results of operations, and cash flows.

SEC original ↗Healthequity, Inc. — 10-Q Quarterly report10-QAug 27, 2026